Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Present and Future of Prostate Cancer Urine Biomarkers

  • Rigau, Marina|||0000-0002-1691-454X
  • Olivan, Mireia|||0000-0002-8464-0827
  • García, Marta|||0000-0001-5155-4730
  • Sequeiros, Tamara|||0000-0002-0908-2263
  • Montes, Melania|||0000-0002-4268-6608
  • Colás Ortega, Eva|||0000-0003-0302-4828
  • Llauradó i Miravall, Marta
  • Planas Morin, Jacques|||0000-0002-0222-584X
  • de Torres, Inés|||0000-0002-5495-9140
  • Morote Robles, Juan|||0000-0002-2168-323X
  • Cooper, Colin
  • Reventós, Jaume
  • Clark, Jeremy
  • Doll, Andreas|||0000-0001-8965-8682
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. Current screening techniques lack specificity, and a decisive diagnosis of PCa is based on prostate biopsy. Although PCa screening is widely utilized nowadays, two thirds of the biopsies performed are still unnecessary. Thus the discovery of non-invasive PCa biomarkers remains urgent. In recent years, the utilization of urine has emerged as an attractive option for the non-invasive detection of PCa. Moreover, a great improvement in high-throughput "omic" techniques has presented considerable opportunities for the identification of new biomarkers. Herein, we will review the most significant urine biomarkers described in recent years, as well as some future prospects in that field.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues

  • Sequeiros, Tamara|||0000-0002-0908-2263
  • García, Marta|||0000-0001-5155-4730
  • Montes, Melania|||0000-0002-4268-6608
  • Olivan, Mireia|||0000-0002-8464-0827
  • Rigau, Marina|||0000-0002-1691-454X
  • Colás Ortega, Eva|||0000-0003-0302-4828
  • de Torres, Inés|||0000-0002-5495-9140
  • Morote Robles, Juan|||0000-0002-2168-323X
  • Reventós Puigjaner, Jaume|||0000-0002-2154-6593
  • Doll, Andreas|||0000-0001-8965-8682
Prostate cancer (PCa) is the most frequently diagnosed type of cancer in developed countries. The decisive method of diagnosis is based on the results of biopsies, morphologically evaluated to determine the presence or absence of cancer. Although this approach leads to a confident diagnosis in most cases, it can be improved by using the molecular markers present in the tissue. Both miRNAs and proteins are considered excellent candidates for biomarkers in formalin-fixed paraffin-embedded (FFPE) tissues, due to their stability over long periods of time. In the last few years, a concerted effort has been made to develop the necessary tools for their reliable measurement in these types of samples. Furthermore, the use of these kinds of markers may also help in establishing tumor grade and aggressiveness, as well as predicting the possible outcomes in each particular case for the different treatments available. This would aid clinicians in the decision-making process. In this review, we attempt to summarize and discuss the potential use of microRNA and protein profiles in FFPE tissue samples as markers to better predict PCa diagnosis, progression, and response to therapy.